Sign inCreate account

Report workspace tools

NCT07398027NOT_YET_RECRUITINGanonymous

Post-Market Study of Transbronchial Cryo-assisted RFA During Robotic Assisted Bronchoscopy With Subsequent Surgical Resection (CRONOS-CH)

Sponsor

Source record

Carolin Steinack

Phase

Source record

NA

Modality

AI-normalized

medical device

Target

AI-normalized

HybridTherm® System

Indication / condition

AI-normalized

Lung Cancer

Intervention

Source record

HybridTherm® System

Source & freshness

Source record

NCT ID

NCT07398027

Original source

ClinicalTrials.gov

Source last updated

Feb 09, 2026

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT07398027

Title

Post-Market Study of Transbronchial Cryo-assisted RFA During Robotic Assisted Bronchoscopy With Subsequent Surgical Resection (CRONOS-CH)

Sponsor

Carolin Steinack

Status

NOT_YET_RECRUITING

Phase

NA

Condition raw

Lung Cancer

Condition normalized

Lung Cancer

Modality raw

non-small cell lung cancer

Modality normalized

medical device

Target raw

HybridTherm® System

Target normalized

HybridTherm® System

Interventions

HybridTherm® System

Public preview

Source record

Post-Market Study of Transbronchial Cryo-assisted RFA During Robotic Assisted Bronchoscopy With Subsequent Surgical Resection (CRONOS-CH) is a NA clinical asset sponsored by Carolin Steinack in Lung Cancer. SEO and diligence focus: HybridTherm® System, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Post-Market Study of Transbronchial Cryo-assisted RFA During Robotic Assisted Bronchoscopy With Subsequent Surgical Resection (CRONOS-CH)

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT07398027

Status

NOT_YET_RECRUITING

Phase

NA

Sponsor

Carolin Steinack

Executive brief

Investment-Ready Snapshot

Post-Market Study of Transbronchial Cryo-assisted RFA During Robotic Assisted Bronchoscopy With Subsequent Surgical Resection (CRONOS-CH) is a NA clinical asset sponsored by Carolin Steinack in Lung Cancer. SEO and diligence focus: HybridTherm® System, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedFeb 09, 2026
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT07398027

Indication

Lung Cancer

Modality

medical device

Target

HybridTherm® System

Intervention

HybridTherm® System

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.